Concepedia

Yoshiya Horimoto

YH

Statistics

Publications

47

Citations

1.6K

H-Index

23

Active since

2009

Affiliations

Juntendo University(Current)

Japanese Foundation For Cancer Research

Imperial College London

Kumamoto City Hospital

Nagoya City University

Yoshiya Horimoto is an author at Juntendo University specializing in medicine, oncology, and breast oncology.

ORCID

Publications per year

2009–2022

47

Publications

47

ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance

Julie Millour, Natalia de Olano, Yoshiya Horimoto et al. · Molecular Cancer Therapeutics · 2011 · 190 citations · Full text

, , +16

Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target

Shinsaku Togo, Urszula M. Polanska, Yoshiya Horimoto et al. · Cancers · 2013 · 158 citations · Full text

, , +17

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

Yoshiya Horimoto, Emi Tokuda, Fumi Murakami et al. · Journal of Translational Medicine · 2018 · 69 citations · Full text

, , +17

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases

Yoshiya Horimoto, Atsushi Arakawa, Noriko Sasahara et al. · PLoS ONE · 2016 · 61 citations · Full text

, , +17

Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma

Jayson Wang, Alexandra Taylor, Rania Showeil et al. · Cytokine · 2014 · 57 citations

, , +13

1–5 of 47